Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Personalized Multi-peptide Vaccination in CLL Patients [Phase 1]
This update notes the completion of a Phase 1 trial evaluating a personalized multi-peptide vaccination in patients with chronic lymphocytic…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma [Phase 4]
Phase 4 clinical trial update: acalabrutinib in Indian patients with chronic lymphocytic leukemia and relapsed/refractory mantle cell lympho…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: APR-246 in Combination With Acalabrutinib or Venetoclax Based Therapy in Subjects With R/R Non Hodgkin Lymphomas (NHL) [Phase 1, Phase 2]
A Phase 1/Phase 2 trial of APR-246 in combination with acalabrutinib or venetoclax in relapsed/refractory non-Hodgkin lymphoma has been term…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: A Study to Evaluate Activity, Safety and Tolerability of ZX-101A in Relapsed/Refractory Hematological Malignancies [Phase 1, Phase 2]
Update on the completed Phase 1/2 study of ZX-101A assessing activity, safety, and tolerability in relapsed/refractory hematological maligna…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies [Phase 1]
A Phase 1 clinical trial evaluating the safety and tolerability of XmAb13676 (plamotamab) in CD20-expressing hematologic malignancies has co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL [Phase 1]
Phase 1 trial evaluating haploidentical stem cell transplantation with prophylactic natural killer donor lymphocyte infusion in lymphoma, mu…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: MargheRITA (Remote Intelligence for Therapeutic Adherence) [NA]
A completed clinical trial named MargheRITA (Remote Intelligence for Therapeutic Adherence) sponsored by Advice Pharma Group srl studied tre…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial update on a Triplex CMV vaccine designed to prevent CMV infection in patients undergoing hematopoietic stem cell tran…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL [Phase 2]
Phase 2 study evaluating idelalisib plus ofatumumab in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma; the…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 study of the intravenous agent S65487 in relapsed or refractory hematologic cancers (acute myeloid leukemia, non-Hodgkin lymphoma, m…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating acalabrutinib in combination with high-frequency, low-dose subcutaneous rituximab in previously untreated chronic l…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 2]
Phase 2 trial update showing results for ofatumumab in high-risk chronic lymphocytic leukemia and small lymphocytic lymphoma, with trial res…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 3]
Open-label extension Phase 3 study in patients aged 65 and older with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma; results po…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS [Phase 1]
Phase I study of CYC140, a PLK-1 inhibitor, in advanced leukemias and myelodysplastic syndromes has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: CAR20.19.22 T-cells in Relapsed, Refractory B-cell Malignancies [Phase 1]
Phase 1 study of CAR20.19.22 T-cells in relapsed/refractory B-cell malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma [Phase 1]
Phase I dose-escalation study evaluating the safety and pharmacokinetics of LAM-002A in patients with Non-Hodgkin lymphoma and chronic lymph…
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies [Phase 1]
Phase 1 trial update for CLBR001 and SWI019 in relapsed/refractory B-cell malignancies has completed enrollment in a study targeting multipl…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas [Phase 1, Phase 2]
First-in-human study of GEN3009 in relapsed or refractory B-cell non-Hodgkin lymphomas was terminated, with results posted thereafter.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 clinical trial update evaluating intermittent dosing of duvelisib in patients with chronic lymphocytic leukemia or small lymphocytic…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A terminated clinical trial update investigates immune responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia or sma…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: The clonoSEQ® Watch Registry
Clinical trial update for the clonoSEQ Watch Registry sponsored by Adaptive Biotechnologies; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Study of TG-1801 Alone or in Combination With Ublituximab in Subjects With B-Cell Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 study assessing TG-1801 alone or with ublituximab in patients with CLL, SLL, and other B-cell lymphomas was terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 1]
Phase 1 safety and preliminary efficacy study of CC-99282 in combination with obinutuzumab in patients with relapsed or refractory chronic l…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase I dose-escalation study of oral S-55746 in patients with chronic lymphocytic leukemia and B-cell non-Hodgkin lymphoma completed.
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression [Phase 3]
Phase 3 trial evaluating haploidentical allogeneic peripheral blood transplantation with analysis of checkpoint immune regulator expression;…